AI assistant
Sending…
Amphastar Pharmaceuticals, Inc. — Director's Dealing 2014
Aug 20, 2014
10216_dirs_2014-08-19_18038b5b-9c07-47ec-9135-3b2eef28d557.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2014-08-15
Reporting Person: Shohet Stephen B. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-08-15 | Common Stock | P | 3500 | $10.37 | Acquired | 3500 | Direct |
More from Amphastar Pharmaceuticals, Inc.
Investor Presentation
2026
May 14
Interim / Quarterly Report
2026
May 7
Investor Presentation
2026
May 7
Investor Presentation
2026
Apr 14
Annual Report
2026
Apr 13
Proxy Solicitation & Information Statement
2026
Apr 13
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17